Lipid nanoparticles─ from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement
R Tenchov, R Bird, AE Curtze, Q Zhou - ACS nano, 2021 - ACS Publications
Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising
vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of …
vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of …
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
FX Heinz, K Stiasny - npj Vaccines, 2021 - nature.com
COVID-19 vaccines were developed with an unprecedented pace since the beginning of the
pandemic. Several of them have reached market authorization and mass production …
pandemic. Several of them have reached market authorization and mass production …
Impact of COVID-19 pandemic on socio-economic, energy-environment and transport sector globally and sustainable development goal (SDG)
Abstract The United Nation's Sustainable Development Goals (SDGs) want to have a
peaceful world where human life will be in a safe, healthy, sustainable environment without …
peaceful world where human life will be in a safe, healthy, sustainable environment without …
Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review
Background and aims Although vaccines are considered the most effective and fundamental
therapeutic tools for consistently preventing the COVID-19 disease, worldwide vaccine …
therapeutic tools for consistently preventing the COVID-19 disease, worldwide vaccine …
Cutaneous findings following COVID‐19 vaccination: review of world literature and own experience
T Gambichler, S Boms, L Susok… - Journal of the …, 2022 - Wiley Online Library
There is growing evidence that not only the novel coronavirus disease (COVID‐19) but also
the COVID‐19 vaccines can cause a variety of skin reactions. In this review article, we …
the COVID‐19 vaccines can cause a variety of skin reactions. In this review article, we …
PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective
Lipid nanoparticles (LNPs) have been recognized as efficient vehicles to transport a large
variety of therapeutics. Currently in the spotlight as important constituents of the COVID-19 …
variety of therapeutics. Currently in the spotlight as important constituents of the COVID-19 …
Glycoconjugates: synthesis, functional studies, and therapeutic developments
Glycoconjugates are major constituents of mammalian cells that are formed via covalent
conjugation of carbohydrates to other biomolecules like proteins and lipids and often …
conjugation of carbohydrates to other biomolecules like proteins and lipids and often …
COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …
Viral vector‐based gene therapies in the clinic
Gene therapies are currently one of the most investigated therapeutic modalities in both the
preclinical and clinical settings and have shown promise in treating a diverse spectrum of …
preclinical and clinical settings and have shown promise in treating a diverse spectrum of …
Progress and challenges in targeting the SARS-CoV-2 papain-like protease
SARS-CoV-2 is the causative agent of the COVID-19 pandemic. The approval of vaccines
and small-molecule antivirals is vital in combating the pandemic. The viral polymerase …
and small-molecule antivirals is vital in combating the pandemic. The viral polymerase …